Newsletter Archive

21. 04.29.21 -- Overcoming The Raw Material Hurdle: Plasmids For Viral Vector-Based Gene Therapies 4/29/2021
    04/29/21 BioProcess Online Newsletter
22. 04.28.21 -- Automating Vector Characterization 4/28/2021
    04/28/21 BioProcess Online Newsletter
23. 04.28.21 -- Decentralized Cell Therapy Production In Practice 4/28/2021
    04/28/21 BioProcess Online Newsletter
24. 04.27.21 -- Data-Driven Lyophilization Process Shortens Time To Market 4/27/2021
    04/27/21 BioProcess Online Newsletter
25. 04.26.21 -- Considerations For A Successful Process Development 4/26/2021
    04/26/21 BioProcess Online Newsletter
26. 04.26.21 -- The Year's Best Biologics Clinical Research 4/26/2021
    04/26/21 BioProcess Online Newsletter
27. 04.22.21 -- Mapping 7 Emerging Pharma Development Risks 4/22/2021
    04/22/21 BioProcess Online Newsletter
28. 04.21.21 -- Integrating Market Intelligence For Aseptic Fill/Finish 4/21/2021
    04/21/21 BioProcess Online Newsletter
29. 04.21.21 -- Rating Risk: End Of The Risk Priority Number? 4/21/2021
    04/21/21 BioProcess Online Newsletter
30. 04.20.21 -- Improved Bioavailability In 12 Weeks 4/20/2021
    04/20/21 BioProcess Online Newsletter